NCT01261754 A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01257425 Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg Status COMPLETED Phase PHASE2
NCT01254864 Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies Status COMPLETED Phase PHASE2
NCT01254513 Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients Status COMPLETED Phase PHASE2
NCT01253213 BR55 in Prostate Cancer: an Exploratory Clinical Trial Status COMPLETED Phase EARLY_PHASE1
NCT01252693 International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer Status COMPLETED Phase PHASE2
NCT01250717 Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT01250483 Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) Status COMPLETED Phase N/A
NCT01248741 CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse Status COMPLETED Phase NA
NCT01244568 Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2 Status COMPLETED Phase NA
NCT01243385 Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT01240629 Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01238172 Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Status COMPLETED Phase PHASE3
NCT01234350 A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON Status COMPLETED Phase N/A
NCT01234311 A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT01231932 Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors Status TERMINATED Phase N/A
NCT01230905 Study to Monitor the Effects of Androgen Suppression Treatment on the Heart Status COMPLETED Phase PHASE4
NCT01230866 Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3